Ensign Peak Advisors Inc decreased its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 29.2% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 164,745 shares of the medical instruments supplier’s stock after selling 68,023 shares during the quarter. Ensign Peak Advisors Inc owned about 0.23% of West Pharmaceutical Services worth $54,265,000 as of its most recent SEC filing.
Several other institutional investors have also bought and sold shares of the business. Pitcairn Co. raised its position in shares of West Pharmaceutical Services by 3.4% during the 1st quarter. Pitcairn Co. now owns 875 shares of the medical instruments supplier’s stock valued at $346,000 after buying an additional 29 shares in the last quarter. Copperwynd Financial LLC lifted its stake in shares of West Pharmaceutical Services by 4.0% in the 4th quarter. Copperwynd Financial LLC now owns 778 shares of the medical instruments supplier’s stock valued at $274,000 after purchasing an additional 30 shares during the last quarter. Clearbridge Investments LLC boosted its holdings in shares of West Pharmaceutical Services by 0.7% in the 1st quarter. Clearbridge Investments LLC now owns 4,495 shares of the medical instruments supplier’s stock worth $1,779,000 after purchasing an additional 31 shares during the period. RFG Advisory LLC increased its position in shares of West Pharmaceutical Services by 2.3% during the 1st quarter. RFG Advisory LLC now owns 1,465 shares of the medical instruments supplier’s stock valued at $580,000 after purchasing an additional 33 shares during the last quarter. Finally, Ballentine Partners LLC raised its holdings in West Pharmaceutical Services by 4.7% during the 2nd quarter. Ballentine Partners LLC now owns 742 shares of the medical instruments supplier’s stock valued at $244,000 after buying an additional 33 shares during the period. Institutional investors own 93.90% of the company’s stock.
West Pharmaceutical Services Stock Down 1.0 %
NYSE WST opened at $308.15 on Friday. The company has a quick ratio of 1.68, a current ratio of 2.34 and a debt-to-equity ratio of 0.03. West Pharmaceutical Services, Inc. has a 52 week low of $265.00 and a 52 week high of $413.70. The firm has a market capitalization of $22.45 billion, a price-to-earnings ratio of 40.65, a PEG ratio of 10.58 and a beta of 1.01. The company has a fifty day moving average of $303.37 and a two-hundred day moving average of $337.31.
Insider Transactions at West Pharmaceutical Services
In related news, VP Charles Witherspoon sold 1,029 shares of the business’s stock in a transaction on Monday, August 19th. The stock was sold at an average price of $300.00, for a total transaction of $308,700.00. Following the completion of the transaction, the vice president now owns 1,478 shares in the company, valued at approximately $443,400. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.53% of the company’s stock.
West Pharmaceutical Services Profile
West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
See Also
- Five stocks we like better than West Pharmaceutical Services
- How to Plot Fibonacci Price Inflection Levels
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- MarketBeat Week in Review – 9/16 – 9/20
- Consumer Staples Stocks, Explained
- Don’t Miss These 3 Retail Stocks for Fall Gains
Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WST – Free Report).
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.